Prana Biotechnology Ltd (NASDAQ:PRAN)

1.15
Delayed Data
As of Mar 27
 +0.03 / +2.68%
Today’s Change
1.07
Today|||52-Week Range
10.36
-29.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$56.2M

Company Description

Prana Biotechnology Ltd. is focused on the research and development of treatments for Alzheimer's, Huntington's disease and other major age related degenerative disorders. It is developed a proprietary library of class chemical compounds, which is combined with a drug development program to explore novel therapeutics in multiple disease indications. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.

Contact Information

Prana Biotechnology Ltd.
369 Royal Parade
Parkville Victoria (vic) 3052
P:(139) 349-4906
Investor Relations:

Employees

Shareholders

Other institutional1.46%
Mutual fund holders0.02%
Individual stakeholders--

Top Executives

Geoffrey Paul KemplerExecutive Chairman & Chief Executive Officer
Dianne AngusChief Operating Officer
Phillip A. HainsChief Financial Officer

To view my watchlist

Not a member yet?

Sign up now for a free account